Bivalent RSV Vaccine Candidate Gets Priority Review for Older Adults
The BLA is supported by data from the phase 3 RENOIR trial which included approximately 37,000 adults 60 years of age and older.
Immunization
Pfizer, BioNTech Submit EUA Request for Bivalent COVID-19 Vaccine in Younger Children
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Flu Shots Cut Some Cardiac Complications in Patients With Heart Failure
Less pneumonia, fewer cardiovascular events, deaths, hospitalizations seen during peak flu season
Measles Vaccination Rates Dropped During Pandemic to 81% in 2021
Number of estimated measles deaths decreased 83 percent during 2000 to 2021; estimated 56 million deaths prevented by vaccination
Tetravalent Dengue Vaccine Candidate Granted Priority Review
The BLA is supported by data from the pivotal TIDES trial which included over 20,000 patients 4 to 16 years of age.
New Pfizer Booster Shot Shows Protection Against Emerging Omicron Variants
In early data, new Pfizer COVID-19 boosters marshal antibodies against newer omicron variants
CDC: Priorix, M-M-R II Fully Interchangeable for MMR Vaccination
Immune responses after Priorix administration were noninferior to those observed with M-M-R II.
Moderna Booster Shot Prompts Strong Immune Response Against Omicron Subvariants
Moderna reports its updated booster shot is indeed triggering a strong immune response to the omicron variants BA.5 and BA.4
New Formulation of Rotarix Removes the Need for Reconstitution
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
Routine Vaccination Coverage Decreased in 2021 Worldwide
Coverage levels for three doses of DTP-containing vaccine, measles-containing vaccine down to lowest levels since 2008
